Meet with Modular Medical CEO, Jeb BesserThere are more than 3 million individuals who use daily insulin to help with the care of Diabetes in the US. 100% of patient population require daily insulin injection. Only 20% currently use an insulin pump.Discover how...
Modular Medical to Attend the Benchmark Company’s Upcoming Discovery One-on-One Investor Conference
SAN DIEGO, CA / November 14, 2023 / Modular Medical, Inc. (Nasdaq:MODD) ("Modular Medical" or the "Company"), a development-stage, insulin delivery technology company seeking to launch the next generation of user-friendly and affordable insulin pump technology, today...
Modular Medical Updates Test Progress and Submission Timeline
SAN DIEGO, CA / October 31, 2023 / Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical" or the "Company"), a development stage insulin delivery technology company seeking to launch the next generation of user-friendly and affordable insulin pump technology, today...
Modular Medical Partners with Phillips-Medisize to Expand Insulin Delivery Alternatives
SAN DIEGO, CA / August 16, 2023 / Modular Medical, Inc. (Nasdaq:MODD), a development stage insulin delivery technology company seeking to launch the next generation of user-friendly and affordable insulin pump technology, today announced a collaboration under which...
Modular Medical to Present at the Sidoti Micro-Cap Virtual Conference on August 17
SAN DIEGO, CA / August 10, 2023 / Modular Medical, Inc. (the "Company" or "Modular Medical") (Nasdaq:MODD), a development stage insulin delivery technology company seeking to launch the next generation of easy to use and affordable insulin pump technology, today...
Modular Medical Announces Diabetes Industry Veteran Duane DeSisto Will Join the Board of Directors
SAN DIEGO, CA / July 6, 2023 / Modular Medical, Inc. (the "Company" or "Modular Medical") (NASDAQ:MODD), a development stage insulin delivery technology company seeking to launch the next generation of easy to use and affordable insulin pump technology, today...
Modular Medical Announces Full Exercise of Underwriter’s Option to Purchase Additional Shares
SAN DIEGO, CA / May 25, 2023 / Modular Medical, Inc. (the "Company" or "Modular Medical") (Nasdaq:MODD), a development stage insulin delivery technology company seeking to launch the next generation of easy to use and affordable insulin pump technology, today...
Modular Medical Announces Pricing of Upsized $9.4 Million Public Offering
SAN DIEGO, CA / May 16, 2023 / Modular Medical, Inc. (the "Company" or "Modular Medical") (Nasdaq:MODD), a development stage insulin delivery technology company seeking to launch the next generation of easy to use and affordable insulin pump technology, today...
Modular Medical Provides Update on FDA Submission Strategy
SAN DIEGO, CA / January 25, 2023 / Modular Medical, Inc. (the "Company" or "Modular Medical") (NASDAQ:MODD), a development stage insulin delivery technology company seeking to launch the next generation of easy to use and affordable insulin pump technology, today...
Modular Medical Announces Product Testing Update
SAN DIEGO, CA / November 28, 2022 / Modular Medical, Inc. (the "Company" or "Modular Medical") (NASDAQ:MODD), a development stage, insulin delivery technology company seeking to launch the next generation of easy to use and affordable insulin pump technology, today...